Vascular Disease and Thrombosis

Science News

Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries
Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations
Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018
Relationship Between Depressive Symptoms and Health Status in Peripheral Artery Disease: Role of Sex Differences

Continuing Education

Registration Now Open

PVD Council partners are focused on improving the care of patients with vascular diseases by advancing science, education, advocacy, and improved healthcare delivery. Partners support the AHA mission through active involvement in the council’s scientific initiatives and educational programs, including the annual Scientific Sessions and Vascular Discovery meetings.


The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, partners can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The 3CPR Council’s areas of focus encompass integrated cardiopulmonary physiology, critical care, emergency cardiovascular care, and CPR. The council takes a bench-to-bedside and community approach to clinical care, research, and basic science. Pulmonary hypertension and regulation of pulmonary circulation have been topics of ongoing attention.


VOYAGER PAD | Marc Bonaca, MD, MPH

Investigator Marc Bonaca, MD, MPH reports the results of the VOYAGER PAD trial, which examined reducing the risk of adverse limb and cardiovascular outcomes in patients with lower extremity PAD after intervention. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.

American Heart Association Professional Partners

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses